<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Emorragia Intracerebrale - Guida Tascabile</title>
    <style>
        * { box-sizing: border-box; }
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            margin: 0;
            padding: 4px;
            background: white;
            color: #333;
            line-height: 1.2;
        }
        .container { max-width: 800px; margin: 0 auto; background: white; }
        .header {
            background: #2c3e50;
            color: white;
            padding: 8px;
            text-align: center;
            font-weight: bold;
            font-size: clamp(12px, 4vw, 18px);
            margin-bottom: 8px;
            border-radius: 4px;
        }
        .timeline {
            background: #e74c3c;
            color: white;
            padding: 6px;
            font-size: clamp(10px, 3vw, 14px);
            font-weight: bold;
            text-align: center;
            margin-bottom: 6px;
            border-radius: 4px;
        }
        .section {
            margin-bottom: 8px;
            border: 1px solid #ddd;
            border-radius: 6px;
            overflow: hidden;
            box-shadow: 0 2px 4px rgba(0,0,0,0.1);
        }
        .drug-row {
            padding: 8px;
            border-bottom: 1px solid #eee;
            background: #f8f9fa;
        }
        .drug-row:last-child { border-bottom: none; }
        .drug-name {
            font-weight: bold;
            color: #2c3e50;
            font-size: clamp(11px, 3.5vw, 16px);
            margin-bottom: 4px;
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 4px;
        }
        .dose-info {
            font-size: clamp(9px, 3vw, 13px);
            margin-bottom: 4px;
            color: #555;
            font-weight: 500;
        }
        .weight-doses {
            font-size: clamp(8px, 2.5vw, 11px);
            color: #666;
            margin-bottom: 4px;
            background: #e8f4f8;
            padding: 4px;
            border-radius: 3px;
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(60px, 1fr));
            gap: 4px;
        }
        .weight-doses span {
            background: #fff;
            padding: 2px 4px;
            border-radius: 2px;
            text-align: center;
            font-size: clamp(7px, 2vw, 10px);
        }
        .preparation {
            font-size: clamp(8px, 2.5vw, 11px);
            color: #0066cc;
            font-style: italic;
            margin-bottom: 4px;
            background: #f0f7ff;
            padding: 4px;
            border-radius: 3px;
            border-left: 3px solid #0066cc;
        }
        .contraindications {
            font-size: clamp(8px, 2.5vw, 11px);
            color: #cc0000;
            margin-bottom: 4px;
            background: #fff5f5;
            padding: 4px;
            border-radius: 3px;
            border-left: 3px solid #cc0000;
        }
        .emergency-note {
            background: #f39c12;
            color: white;
            padding: 8px;
            font-size: clamp(9px, 3vw, 13px);
            text-align: center;
            font-weight: bold;
            margin-bottom: 8px;
            border-radius: 6px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.2);
        }
        .stabilization {
            background: #27ae60;
            color: white;
            padding: 8px;
            font-size: clamp(9px, 3vw, 13px);
            text-align: center;
            font-weight: bold;
            margin-bottom: 8px;
            border-radius: 6px;
            box-shadow: 0 2px 4px rgba(0,0,0,0.2);
        }
        .max-dose { color: #e74c3c; font-weight: bold; }
        .route {
            background: #3498db;
            color: white;
            padding: 2px 6px;
            border-radius: 12px;
            font-size: clamp(7px, 2vw, 10px);
            font-weight: bold;
        }
        .repeat {
            background: #9b59b6;
            color: white;
            padding: 2px 6px;
            border-radius: 12px;
            font-size: clamp(7px, 2vw, 10px);
            font-weight: bold;
        }
        .speed {
            color: #e67e22;
            font-weight: bold;
            background: #fff3e0;
            padding: 2px 4px;
            border-radius: 3px;
        }
        .references {
            font-size: clamp(8px, 2.5vw, 11px);
            color: #666;
            text-align: center;
            margin-top: 8px;
            border-top: 1px solid #ddd;
            padding-top: 8px;
            background: #f8f9fa;
            padding: 8px;
            border-radius: 6px;
        }
        .table-container {
            overflow-x: auto;
            margin-bottom: 8px;
            border: 1px solid #ddd;
            border-radius: 6px;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            font-size: clamp(8px, 2.5vw, 11px);
        }
        th, td {
            border: 1px solid #ddd;
            padding: 4px;
            text-align: center;
        }
        th {
            background-color: #f2f2f2;
            font-weight: bold;
        }
        .dose-high {
            background-color: #e74c3c;
            color: white;
            padding: 2px 4px;
            border-radius: 3px;
        }
        .dose-low {
            background-color: #f39c12;
            color: white;
            padding: 2px 4px;
            border-radius: 3px;
        }
        .back-link {
            text-align: center;
            margin-top: 20px;
            padding-top: 10px;
            border-top: 1px solid #e9ecef;
        }
        .back-link a {
            color: #3498db;
            text-decoration: none;
            font-size: 1.1em;
            font-weight: bold;
        }
        .contatti {
            text-align: center;
            margin-top: 15px;
            padding: 10px;
            border-top: 1px solid #e9ecef;
            font-size: clamp(9px, 3vw, 12px);
        }
        .social-links {
            display: flex;
            justify-content: center;
            gap: 10px;
            margin-top: 8px;
        }
        .social-link {
            display: flex;
            flex-direction: column;
            align-items: center;
            color: #333;
            text-decoration: none;
            font-size: clamp(8px, 2.5vw, 10px);
        }
        .social-link svg {
            width: 24px;
            height: 24px;
        }
        @media (max-width: 480px) {
            body { padding: 2px; }
            .drug-row { padding: 6px; }
            .weight-doses { grid-template-columns: 1fr; }
            .weight-doses span { display: inline-block; margin-right: 6px; margin-bottom: 2px; }
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">EMORRAGIA INTRACEREBRALE - GUIDA TASCABILE (AHA/ASA 2022)</div>

        <div class="stabilization">
            Ricovero in Stroke Unit (trasferimento in centro con NCH se idrocefalo ostruttivo) + monitoraggio neurologico stretto nelle prime 72h
        </div>

        <div class="section">
            <div class="drug-row">
                <div class="drug-name">Prevenzione Trombosi Venosa Profonda</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li>Compressione pneumatica intermittente <strong>al ricovero</strong></li>
                    <li>Enoxaparina a dose profilattica <strong>dopo 48h</strong>, se stabilità al neuroimaging</li>
                    <li>Filtro cavale in pz con embolia polmonare e TVP → eparina dopo 1-2 settimane</li>
                </ul>
            </div>
        </div>

        <div class="section">
            <div class="drug-row">
                <div class="drug-name">Gestione Glicemia e Febbre</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li>Non diabetici: <strong>109-140 mg/dl</strong></li>
                    <li>Diabetici: <strong>140-180 mg/dl</strong></li>
                    <li>TC ≤ 37,5°</li>
                </ul>
            </div>
        </div>

        <div class="section">
            <div class="drug-row">
                <div class="drug-name">Gestione Ipertensione Endocranica</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li>Elevazione capo <strong>15-30°</strong></li>
                    <li>Eventuale sedazione</li>
                    <li>Diuretici osmotici solo in casi di estrema gravità</li>
                    <li><span style="color: #e74c3c; font-weight: bold;">EVITARE corticosteroidi</span></li>
                </ul>
            </div>
        </div>

        <div class="section">
            <div class="drug-row">
                <div class="drug-name">Gestione Crisi (AHA/ASA 2022)</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li><span style="color: #e74c3c; font-weight: bold;">Non indicata terapia profilattica</span></li>
                    <li>Crisi singola entro 24h: terapia a breve termine</li>
                    <li>Crisi ricorrenti: gestione come epilessia strutturale</li>
                    <li>EEG se alterato stato mentale (escludere stato epilettico non convulsivo)</li>
                </ul>
            </div>
        </div>

        <div class="section">
            <div class="drug-row">
                <div class="drug-name">Gestione Pressione Arteriosa (ESO2021 e AHA/ASA 2022)</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li>Controllo PA ogni <strong>5-10 min</strong> dal ricovero</li>
                    <li>Trattamento aggressivo e tempestivo (entro 2 ore, target PA entro 1 ora)</li>
                    <li>Evitare bruschi abbassamenti o picchi, mantenere MAP > 85 mmHg</li>
                    <li>PAS <strong>150-220 mmHg + ICH lieve-moderata</strong> → target <strong>140 mmHg</strong></li>
                    <li>PAS <strong>> 220 mmHg o ICH grave</strong> → maggior cautela</li>
                    <li>Agenti infusionali: labetalolo, urapidil, enalapril, clevidipina</li>
                    <li>Passare a terapia orale ASAP</li>
                </ul>
            </div>
        </div>

        <div class="section">
            <div class="drug-row">
                <div class="drug-name">Correzione Coagulopatia</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li><span style="color: #e74c3c; font-weight: bold;">Non indicati antifibrinolitici</span> salvo in emorragie secondarie a trombolisi</li>
                    <li>Pazienti con normali parametri coagulativi: <span style="color: #e74c3c; font-weight: bold;">nessun beneficio dimostrato</span> per FVII ricombinante, acido tranexamico</li>
                    <li><strong>Trombocitopenia/trombocitopatia:</strong> se PLT < 50.000 (se prognosi buona anche < 75.000) → pappa piastrinica</li>
                    <li><strong>Piastrinopatia da DAPT/SAPT:</strong> <span style="color: #e74c3c; font-weight: bold;">non raccomandata pappa piastrinica</span>; desmopressina 0,3 µg/kg in 100 ml di S.F. in 15-30 min (beneficio incerto)</li>
                </ul>
            </div>
        </div>

        <div class="section">
            <div class="drug-row">
                <div class="drug-name">Emorragia in Anticoagulanti</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li><strong>Warfarin (INR ≥ 2):</strong> complesso protrombinico 30 UI/KG + vit K 10 mg EV (entro 1h dalla TC, se GCS > 5)</li>
                    <li><strong>Dabigatran:</strong> idarucizumab (2 flaconi da 2,5 g in successione, max 15' tra loro) o complesso protrombinico 4F</li>
                    <li><strong>Apixaban/Rivaroxaban/Edoxaban:</strong> Andexanet-Alfa (entro 2h dalla TC, entro 15h dall’assunzione)</li>
                </ul>
            </div>
        </div>

        <div class="table-container">
            <table>
                <thead>
                    <tr>
                        <th rowspan="2">FXa inibitore</th>
                        <th rowspan="2">Last dose</th>
                        <th colspan="3">Time since last dose</th>
                    </tr>
                    <tr>
                        <th>&lt; 8 ore</th>
                        <th>≥ 8 ore</th>
                        <th>Unknown</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td rowspan="2">Apixaban</td>
                        <td>≤ 5 mg</td>
                        <td class="dose-low">LOW</td>
                        <td class="dose-low">LOW</td>
                        <td class="dose-high">HIGH</td>
                    </tr>
                    <tr>
                        <td>> 5 mg</td>
                        <td class="dose-high">HIGH</td>
                        <td class="dose-low">LOW</td>
                        <td class="dose-high">HIGH</td>
                    </tr>
                    <tr>
                        <td rowspan="2">Rivaroxaban</td>
                        <td>≤ 10 mg</td>
                        <td class="dose-low">LOW</td>
                        <td class="dose-low">LOW</td>
                        <td class="dose-high">HIGH</td>
                    </tr>
                    <tr>
                        <td>> 10 mg</td>
                        <td class="dose-high">HIGH</td>
                        <td class="dose-low">LOW</td>
                        <td class="dose-high">HIGH</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="table-container">
            <table>
                <thead>
                    <tr>
                        <th>Dose</th>
                        <th>Bolus IV</th>
                        <th>Infusione continua</th>
                        <th>N° flaconi</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td class="dose-low">LOW</td>
                        <td>400 mg (40 mL, 180 mL/h, 15 min)</td>
                        <td>480 mg (48 mL, 24 mL/h, 120 min)</td>
                        <td>5</td>
                    </tr>
                    <tr>
                        <td class="dose-high">HIGH</td>
                        <td>800 mg (80 mL, 180 mL/h, 30 min)</td>
                        <td>960 mg (96 mL, 48 mL/h, 120 min)</td>
                        <td>9</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="section">
            <div class="drug-row">
                <div class="drug-name">Trattamento Chirurgico</div>
                <div style="font-weight: bold; color: #27ae60; margin-bottom: 8px;">Indicata chirurgia (entro 12-96h)</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li>Ematoma sovratentoriale <strong>30-60 mL</strong>, vicino superficie + alterazione coscienza (specie < 65 aa)</li>
                    <li>Ematoma cerebellare <strong>> 3 cm (>10-15 mL)</strong> o compressione troncoencefalica ± idrocefalo</li>
                </ul>
                <div style="font-weight: bold; color: #e74c3c; margin-bottom: 8px;">Non indicata chirurgia</div>
                <ul style="margin: 0 0 8px 15px; padding: 0; font-size: clamp(9px, 3vw, 13px);">
                    <li>Ematoma profondo sottocorticale <strong>> 60 mL</strong> e GCS ≤ 8</li>
                    <li>Ematoma sovratentoriale <strong>&lt; 30 mL</strong></li>
                    <li>Sintomi stabili senza erniazione</li>
                    <li>Ematoma troncoencefalo o cerebellare <strong>&lt; 3 cm</strong> senza compressione/idrocefalo</li>
                    <li>Chirurgia urgente prima delle 4 ore dall’inizio dei sintomi</li>
                </ul>
            </div>
        </div>

        <div class="back-link">
            <a href="../index.html">← Torna all'indice principale</a>
        </div>

        <div class="contatti">
            <p>
                <strong>Contatti:</strong> Per segnalare errori o suggerimenti:<br>
                <span id="email"></span>
            </p>
            <div class="social-links">
                <a href="https://mastodon.social/@fedele9" target="_blank" rel="noopener noreferrer" class="social-link">
                    <svg width="24" height="24" viewBox="0 0 24 24" fill="#6364FF">
                        <path d="M21.327 8.566c0-4.339-2.843-5.61-2.843-5.61-1.433-.658-3.894-.935-6.451-.956h-.063c-2.557.021-5.016.298-6.45.956 0 0-2.843 1.272-2.843 5.61 0 .993-.019 2.181.012 3.441.103 4.243.778 8.425 4.701 9.463 1.809.479 3.362.579 4.612.51 2.268-.126 3.542-.809 3.542-.809l-.075-1.646s-1.621.511-3.441.449c-1.804-.062-3.707-.194-3.999-2.409a4.523 4.523 0 0 1-.04-.621s1.77.433 4.014.536c1.372.063 2.658-.08 3.965-.236 2.506-.299 4.688-1.843 4.962-3.254.434-2.223.398-5.424.398-5.424zm-3.353 5.59h-2.081V9.057c0-1.075-.452-1.62-1.357-1.62-1 0-1.501.647-1.501 1.927v2.791h-2.069V9.364c0-1.28-.501-1.927-1.502-1.927-.905 0-1.357.545-1.357 1.62v5.099H6.026V8.903c0-1.074.273-1.927.823-2.558.566-.631 1.307-.955 2.228-.955.892 0 1.58.343 2.077 1.032l.451.757.452-.757c.497-.689 1.185-1.032 2.077-1.032.92 0 1.662.324 2.228.955.55.631.823 1.484.823 2.558v5.253z"/>
                    </svg>
                    Mastodon
                </a>
                <a href="https://gram.social/Fedele" target="_blank" rel="noopener noreferrer" class="social-link">
                    <svg width="24" height="24" viewBox="0 0 24 24" fill="#E1306C">
                        <path d="M12 2.163c3.204 0 3.584.012 4.85.07 3.252.148 4.771 1.691 4.919 4.919.058 1.265.069 1.645.069 4.849 0 3.205-.012 3.584-.069 4.849-.149 3.225-1.664 4.771-4.919 4.919-1.266.058-1.644.07-4.85.07-3.204 0-3.584-.012-4.849-.07-3.26-.149-4.771-1.699-4.919-4.92-.058-1.265-.07-1.644-.07-4.849 0-3.204.013-3.583.07-4.849.149-3.227 1.664-4.771 4.919-4.919 1.266-.057 1.645-.069 4.849-.069zm0-2.163c-3.259 0-3.667.014-4.947.072-4.358.2-6.78 2.618-6.98 6.98-.059 1.281-.073 1.689-.073 4.948 0 3.259.014 3.668.072 4.948.2 4.358 2.618 6.78 6.98 6.98 1.281.058 1.689.072 4.948.072 3.259 0 3.668-.014 4.948-.072 4.354-.2 6.782-2.618 6.979-6.98.059-1.28.073-1.689.073-4.948 0-3.259-.014-3.667-.072-4.947-.196-4.354-2.617-6.78-6.979-6.98-1.281-.059-1.69-.073-4.949-.073zM5.838 12a6.162 6.162 0 1 1 12.324 0 6.162 6.162 0 0 1-12.324 0zM12 16a4 4 0 1 1 0-8 4 4 0 0 1 0 8zm4.965-10.405a1.44 1.44 0 1 1 2.881.001 1.44 1.44 0 0 1-2.881-.001z"/>
                    </svg>
                    Pixelfed
                </a>
                <a href="https://github.com/fedele93" target="_blank" rel="noopener noreferrer" class="social-link">
                    <svg width="24" height="24" viewBox="0 0 24 24" fill="#000">
                        <path d="M12 0c-6.626 0-12 5.373-12 12 0 5.302 3.438 9.8 8.207 11.387.599.111.793-.261.793-.577v-2.234c-3.338.726-4.033-1.416-4.033-1.416-.546-1.387-1.333-1.756-1.333-1.756-1.089-.745.083-.729.083-.729 1.205.084 1.839 1.237 1.839 1.237 1.07 1.834 2.807 1.304 3.492.997.107-.775.418-1.305.762-1.604-2.665-.305-5.467-1.334-5.467-5.931 0-1.311.469-2.381 1.236-3.221-.124-.303-.535-1.524.117-3.176 0 0 1.008-.322 3.301 1.23.957-.266 1.983-.399 3.003-.404 1.02.005 2.047.138 3.006.404 2.291-1.552 3.297-1.23 3.297-1.23.653 1.653.242 2.874.118 3.176.77.84 1.235 1.911 1.235 3.221 0 4.609-2.807 5.624-5.479 5.921.43.372.823 1.102.823 2.222v3.293c0 .319.192.694.801.576 4.765-1.589 8.199-6.086 8.199-11.386 0-6.627-5.373-12-12-12z"/>
                    </svg>
                    GitHub
                </a>
            </div>
        </div>
    </div>

    <script>
        const nome = "neurologiaperschemi.wolf853";
        const dominio = "passinbox.com";
        const email = nome + "@" + dominio;
        document.getElementById("email").innerHTML = `<a href="mailto:${email}">${email}</a>`;
    </script>
</body>
</html>
